Why D-Wave Quantum Stock Jumped 40% Last Month Investors are optimistic about new AI technology that could make quantum computers more efficient.
Is Lucid Stock a Buy After a 10% Owner Scooped Up 55,000 Shares? Luxury EV maker Lucid, known for its high-end electric vehicles, reported a notable insider buy amid ongoing volatility in its share price.
9 Threats to Your Retirement Income in 2026 -- and How to Protect Against Each One Keep these risks -- such as inflation and longevity -- in mind as you plan for a secure retirement.
Which Is the Better Dividend ETF, iShares' HDV or Vanguard's VYM? Expense ratios, sector exposures, and risk profiles set these high-yield ETFs apart. See how their strategies align with different investor priorities.
Bicara Therapeutics Chief Medical Officer Sells 5,500 Shares for $126,000 This Boston biotech specializing in antibody therapies for solid tumors reported a notable insider sale during active clinical development.
Uptick Partners Adds to Its S&P 500 Bet, Buying $3.2 Million Worth of STRV Strive 500 ETF tracks the S&P 500 with a diversified, low-cost portfolio of large-cap U.S. equities for broad market exposure.
Higher Gas and Diesel Prices Are Coming for Consumer Wallets and the Stocks That Depend on Them Gas prices have squeezed consumers' wallets, but that presents a buying opportunity for companies with strong underlying fundamentals.
Investment Advisor Closes Entire Position in ETF, According to Recent SEC Filing PTNQ tracks the NASDAQ-100 with a trend-following strategy, dynamically adjusting exposure between equities and cash equivalents.
Is First Trust's FTGC Commodities ETF a Buy After Climber Capital Purchased Shares Worth $3.8 Million? This ETF employs an actively managed strategy to provide diversified commodity exposure with daily liquidity and transparency for investors.
Berkshire Hathaway's First Annual Meeting Under Greg Abel Has Arrived. Here Are 3 Must-See Takeaways. Berkshire Hathaway is under the leadership of a new CEO, and it sounds like he isn't planning any dramatic changes.
Veeva Systems Just Joined the S&P 500. 3 Reasons to Buy It and 1 Not To. Veeva Systems sits at the intersection of life sciences and enterprise cloud computing.
